Eli Lilly and Company's bioethics framework for human biomedical research

Area of Science:

• Bioethics
• Pharmaceutical Research
• Clinical Trials

Background:

• Existing ethics guidelines lack comprehensive coverage of sponsor bioethical responsibilities in pharmaceutical research.
• Sponsors require a structured approach to navigate complex ethical considerations in human biomedical research.

Purpose of the Study:

• To present Eli Lilly and Company's Bioethics Framework for Human Biomedical Research, developed in 2010.
• To provide a company resource for employee education and bioethics deliberations regarding sponsor responsibilities.

Main Methods:

• The framework is structured around four basic ethical principles and 13 essential elements for ethical human biomedical research.
• Each component is detailed with cross-references to established guidance documents.
• The framework integrates with the company's mission, vision, and values.

Main Results:

• The framework specifies and compiles a sponsor's bioethical responsibilities to multiple stakeholders into a single resource.
• It serves as a bioethical foundation for decision-making throughout the clinical research lifecycle.
• The framework translates ethical aspirations into actionable steps for conducting research.

Conclusions:

• The Bioethics Framework offers a novel compilation of sponsor responsibilities, moving beyond foundational ethical concepts.
• It provides a practical tool for ensuring pharmaceutical human biomedical research aligns with ethical principles and company values.
• Implementation of such a framework supports ethical conduct and decision-making in clinical research.